Article
One-pot, degradable, silica nanocarriers with encapsulated oligonucleotides for mitochondrial specific delivery
2023-08-21
Abstract excerpt
Mutations in nuclear and mitochondrial genes are responsible for severe chronic disorders such as mitochondrial myopathies (MM). Gene therapy using antisense oligonucleotides is a promising strategy to treat mitochondrial DNA (mtDNA) diseases by blocking the replication of the mutated mtDNA. However, transport vehicles are needed for intracellular, mitochondria-specific transport of oligonucleotides. Nanoparticle...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9e137e0b-d85e-58bb-9de3-a1dcd7efda15
- DOI
- 10.21203/rs.3.rs-3231179/v1
